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cu.2012.Abstract Four accurate and sensitive methods were developed and validated for determination of
naphazoline hydrochloride (NAP) and chlorpheniramine maleate (CLO) in the presence of naphazo-
line hydrochloride alkaline degradation product (NAPDeg). The ﬁrst method is a spectrophotometric
one , where NAP was determined by the fourth derivative (D4) spectrophotometric method by mea-
suring the peak amplitude at 302 nm, while CLO was determined by the second derivative of the ratio
spectra (DD2) spectrophotometric method at 276.4 nm. The second method is a chemometric-assisted
spectrophotometric method in which partial least squares (PLS-1) and partial component regression
(PCR) were used for the determination of NAP, CLO and NAP Deg using the information contained
in their absorption spectra of ternary mixture. The third method is a TLC-densitometric one where
NAP,CLOandNAPDegwere separated usingHPTLC silica gel F254 plates using ethyl acetate:meth-
anol:ammonia: (8:2:0.5, by volume) as the developing system followed by densitometric measurement
at 245 nm. The fourthmethod is HPLCmethod whereNAP, CLOandNAPDegwere separated using
ODS C18 column and a mobile phase consisting of 0.1 M KH2PO4 (pH= 7):methanol (55:45 v/v)
delivered at 1.5 mL min1 followed byUV detection at 265 nm. The proposedmethods have been suc-
cessfully applied to the analysis of NAP andCLO in pharmaceutical formulations without interference
from the dosage form additives and the results were statistically compared with a reported method.
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10.0021. Introduction
Naphazoline hydrochloride (NAP) Fig. 1a; [2-(1-naphthyl-
methyl)-2-imidazoline monohydrochloride] is a sympathomi-
metic, which belongs to the imidazole group. It is used as a
vasoconstrictor of a relatively long-lasting action that acts on
the a receptors of the vascular smooth muscle.1hosting by Elsevier B.V. Open access under CC BY-NC-ND license.
Table 1 The concentrations of naphazoline HCl, chlorphe-
niramine maleate and naphazoline HCl degradation product
58 Ned Sayed et al.Chlorpheniramine maleate (CLO) Fig. 1b; [3-(p-chloro-
phenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine] is a powerful
H1-receptor antagonist (anti-histamine), widely used for symp-
tomatic relief of common cold, allergic rhinitis and conjuncti-
vitis, with weak sedative properties.2
Several methods were reported for the determination of
NAP either alone or in the presence of other drugs including
spectrophotometric,3–6 ﬂuorimetric,7,8 liquid chromato-
graphic,9–11 gas chromatographic,12 TLC-densitometric5 meth-
ods. CLO was determined by spectrophotometric,5,13–15 liquid
chromatographic,11,16 TLC-densitometric,6,17,18 polaro-
graphic,19 ﬂuorimetric,20 nuclear magnetic resonance spectro-
metric,21 complexometric,22–24 and potentiometric25 methods
either alone or in the presence of other drugs.
The binary mixture of NAP and CLO is used for their
decongestant and antihistaminic effects. 1-Naphthalene ace-
tic acid (NAP Deg) Fig. 1c, is the alkaline degradation
product of NAP obtained after the reﬂux of NAP with
1 N sodium hydroxide for 2 h.26 NAP Deg is also one of
the potential impurities of NAP in USP27 and BP.28 So
the determination of NAP in the presence of NAP Deg
was necessary. On the other hand CLO was found to be sta-
ble against hydrolysis.29
Reviewing literature on hand, few methods were found
for the determination of NAP and CLO in their binary
mixture.5,15 No analytical methods have been described
for the determination of NAP, CLO in the presence of
NAP Deg, therefore, the aim of this work is to develop
accurate, sensitive, rapid and precise methods for the selec-
tive determination of NAP and CLO in their binary mix-
ture in bulk powder, in laboratory prepared mixtures, in
their pharmaceutical formulations and in the presence of
NAP deg.Figure 1 Chemical structure of (a) naphazoline hydrochloride,
(b) chlorpheniramine maleate and (c) naphazoline hydrochloride
degradation product.2. Materials and Methods
2.1. Instruments
1. A double beam UV–visible spectrophotometer (SHI-
MADZU, Japan) model UV-1601 PC with quartz cell
of 1 cm path length, connected to IBM compatible
computer. The software was UVPC personal spectros-
copy software version 3.7. The spectral bandwidth was
2 nm and wavelength-scanning speed, 2800 nm/min.
2. UV lamp with a short wavelength of 254 nm (USA).
3. PLS-Toolbox for use with MATLAB 6.5.
4. TLC scanner 3 densitometer (Camag, Muttenz, Swit-
zerland).The following requirements are taken into
consideration:
 Slit dimensions: 5 · 0.2 mm.
 Scanning speed: 20 mm/S.
 Spraying rate: 10 s lL1.
 Data resolution: 100 lm/step.
5. TLC plates (20 · 10 cm) coated with silica gel 60F254
(Merck, Germany).
6. Sample applicator for TLC Linomat IV with 100 lL
syringe (Camag, Muttenz, Switzerland).
7. Shimadzu class-LC 10 AD liquid chromatograph sup-
plied a UV–visible spectrophotometer detector, a deg-
asser (DGU-3A) and a data processor (C-R4A) allused in the calibration and validation sets.
Mix No. NAP
(lg mL1)
CLO
(lg mL1)
NAP Deg
(lg mL1)
1 15.00 15.00 9
2 10.00 10.00 5
3 5.00 15.00 7
4 10.00 5.00 9
5 15.00 5.00 5
6 5.00 25.00 5
7 5.00 10.00 13
8 25.00 25.00 7
9 10.00 15.00 13
10 25.00 10.00 9
11 15.00 10.00 7
12 10.00 20.00 7
13 10.00 25.00 11
14 20.00 20.00 13
15 25.00 15.00 11
16 20.00 25.00 9
17 15.00 25.00 13
18 25.00 5.00 13
19 25.00 20.00 5
20 5.00 5.00 11
21 20.00 15.00 5
22 5.00 20.00 9
23 15.00 20.00 11
24 20.00 10.00 11
25 20.00 5.00 7
The concentrations of mixtures used in the validation set are
highlighted.
Figure 2 Zero-order absorption spectra of 30 lg mL1 of naphazoline HCl (- - - -), 30 lg mL1 of chlorpheniramine maleate (––) and
20 lg mL1 naphazoline HCl degradation product (. . ..) using methanol as a solvent.
Figure 3 Fourth derivative absorption spectra of 30 lg mL1 of naphazoline (- - - -), 30 lg mL1 of chlorpheniramine maleate (––) and
20 lg mL1 naphazoline HCl degradation product (. . ..) using methanol as a solvent.
Spectrophotometric, chemometric and chromatographic determination 59from Shimadzu, Kyoto, Japan. The analytical column
was a Phenomenex C18-ODS (Shimadzu, Kyoto,
Japan), 25 cm · 4.6 mm I.D., 5 lm particle size pro-
tected by a C18 guard column.
2.2. Materials
2.2.1. Authentic samples
Naphazoline hydrochloride and chlorpheniramine maleate
were kindly supplied by Egyptian international pharmaceuti-
cal industries CO. (E.I.P.I.CO) (10th of Ramadan City,
Egypt). Their purity was found to be 98.82% and 98.58%,
respectively according to the reported spectrophotometric
method.5 1-Naphthalene acetic acid (NAP Deg) was kindly
supplied by Sigma–Aldrich., Germany. Its purity was re-
ported to be 99.39% according to the company’s analysis
certiﬁcate.2.2.2. Pharmaceutical formulations
Nostamine eye/nose drops (Batch No. 1101185) labeled to
contain 0.5 mg mL1 naphazoline hydrochloride and
0.5 mg mL1 chlorpheniramine maleate is from Egyptian Int.
Pharmaceutical Industries Co. (E.I.P.I.CO), 10th of Ramadan
City, Egypt.
Neozoline eye/nose drops (Batch No. 102301) labeled to
contain 0.5 mg mL1 naphazoline hydrochloride and
0.5 mg mL1 chlorpheniramine maleate is from Amoun Phar-
maceutical Co., El-Obour city, Cairo, Egypt.
Prisoline eye/nose drops (Batch No. 16237) labeled to
contain 0.5 mg mL1 naphazoline hydrochloride and
0.5 mg mL1 chlorpheniramine maleate is from Kahira
Pharm. & Chem. Ind. CO., Cairo, Egypt.
2.2.3. Chemicals and solvents
Ethyl acetate, 33% ammonia solution, methanol, KH2PO4,
phosphoric acid and acetone from (El NASR Pharmaceutical
Table 2 Determination of naphazoline HCl and chlorpheniramine maleate in laboratory proposed mixtures by the proposed
spectrophotometric methods.
% NAP Deg
from NAP
taken Conc.
NAP and
CLO ratio
D4 method At 302 nm DD2 method At 276.4 nm
NAP CLO
Taken lg mL1 Found lg mL1 Recovery* % Taken lg mL1 Found lg mL1 Recovery* %
10 (1:1)a 27 26.44 97.93 27 26.35 97.58
20 1:2 20 19.75 98.77 40 38.96 97.39
30 2:1 20 20.04 100.20 10 9.96 99.60
40 2:3 10 10.56 103.65 15 14.87 99.15
50 3:2 15 16.65 110.97** 10 9.74 97.43
60 3:4 9 10.23 113.72** 12 11.71 97.61
70 4:3 12 13.90 115.85** 9 8.55 95.04**
80 4:5 10 11.62 116.23** 12.5 11.98 95.83**
90 5:4 12.5 14.56 116.46** 10 9.47 94.68**
Mean ± S.D. 100.14 ± 2.522 98.13 ± 0.981
a The dosage form ratio.
* Average of three determinations.
** Rejected value.
60 Ned Sayed et al.Chemicals Co., Abu-Zabaal, Cairo, Egypt). Methanol HPLC
grade (E. Merck, Germany).
2.3. Standard solutions
2.3.1. Stock standard solutions
Stock standard solutions of NAP, CLO and NAP Deg
(1 mg mL1) were prepared by accurately weighing 100 mg
of pure powder of each into three separate 100-mL volumetric
ﬂasks, dissolved in and diluted to the volume with methanol
(in spectrophotometric, chemometric and HPTLC-densitomet-
ric methods) and with methanol:0.1 M KH2PO4 (55:45 v/v) (in
HPLC method).
2.3.2. Working standard solutions
Working standard solutions of NAP, CLO and NAP Deg
(100 lg mL1) were prepared by transferring 10 mL of stock
standard solution of NAP, CLO and NAP Deg (1 mg mL1)
into three separate 100-mL volumetric ﬂasks, diluted to theFigure 4 Second derivative ratio absorption spectra of 30 lg mL1 o
and 20 lg mL1 naphazoline degradation product (. . ..) using 30 lg
methanol as a solvent.volume with methanol (in spectrophotometric, chemometric
and HPTLC-densitometric methods) and with methanol:0.1 M
KH2PO4 (55:45 v/v) (in HPLC method).2.4. Procedures
2.4.1. Derivative and derivative ratio spectrophotometric
methods
2.4.1.1. Construction of calibration curve. Into two separate sets
of 10-mL volumetric ﬂasks, different aliquots containing 50–
400 and 50–450 lg of NAP and CLO, respectively, were accu-
rately transferred from their working solutions; the volume
was then completed with methanol. The zero order absorbance
of each set was recorded in the range of 200–400 nm. For the
determination of NAP, the fourth derivative (D4) curves were
recorded using Dk= 8 and the scaling factor = 1000, the
amplitude values at 302 nm were recorded. For the determina-
tion of CLO the second derivative of the ratio spectra (DD2)
was recorded using 30 lg mL1 of NAP Deg as a divisor,f naphazoline (- - - -), 30 lg mL1 of chlorpheniramine maleate (––)
mL1 of naphazoline HCl degradation product as a divisor and
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Spectrophotometric, chemometric and chromatographic determination 61Dk= 8 and scaling factor = 1000, the amplitude values at
276.4 nm were measured.
The calibration curves were constructed relating the peak
amplitudes against the corresponding drug concentrations
and the regression equations were computed.
2.4.1.2. Analysis of laboratory prepared mixtures of NAP, CLO
and NAP Deg. Mixtures containing different ratios of NAP,
CLO and NAP Deg were prepared and analyzed using the pro-
posed method stated above.
2.4.2. Chemometric-assisted spectrophotometric methods
2.4.2.1. Construction of both training and validation sets. A set
of 25 synthetic mixtures with different concentrations of each
compound were prepared in methanol in the concentration
ranges of 5–25 lg mL1 for NAP, 5–25 lg mL1 for CLO
and 5–13 lg mL1 for NAP Deg as shown in Table 1. The
absorbance of these mixtures was scanned in the range of
200 and 400 nm at 1 nm intervals with respect to a blank of
methanol. The composition of the samples was randomly de-
signed according to a ﬁve level three factor experimental de-
sign.30,31 The PLS and PCR models were constructed, the
training set absorbance and concentration matrices were used
together with PLS-Toolbox 2.0 software for the calculations.
2.4.3. HPTLC-densitometric method
2.4.3.1. Construction of calibration curve. Into a series of 10-mL
volumetric ﬂasks, aliquots equivalent to 0.5–4.5, 0.5–4, 0.6–
1.8 mg, respectively, were accurately transferred from the stan-
dard stock solution of NAP, CLO and NAP Deg (1 mg mL1
in methanol), then the volume was completed with methanol.
Ten microliters of each solution was spotted as bands of
5 mm width on TLC plates (20 · 10 cm) using a Camag Lin-
omat IV applicator. The bands were applied at 5 mm and
15 mm intervals from the bottom and sides. Linear ascending
chromatogram developing to a distance of 9 cm was performed
in a chromatographic tank previously saturated for 1 h with
the developing mobile phase consisting of ethyl acetate:metha-
nol:ammonia solution (8:2:0.5, by volume) at room tempera-
ture. The developed plates were air dried and scanned at
245 nm. The peak areas were recorded and the calibration
curve was constructed by plotting the integrated peak area ver-
sus the corresponding concentrations as lg band1 of each
component and the regression equations were computed.
2.4.4. HPLC method
2.4.4.1. Construction of calibration curve. Aliquots equivalent
of NAP, CLO and NAP Deg were accurately separately trans-
ferred from their corresponding stock standard solutions
(1 mg mL1) into a series of 10-mL volumetric ﬂasks, then
the volume was completed with 0.1 M KH2PO4
(pH = 7):methanol (55:45 v/v) to obtain the ﬁnal dilution of
5–37, 5–50 and 5–35 lg mL1 for NAP, CLO and NAP Deg,
respectively. Triplicate 20 lL injections were made for each
concentration. Chromatograms were recorded under the fol-
lowing instrumental parameters: the ﬂow rate was
1.5 mL min1 at ambient temperature and the efﬂuent was
monitored at 265 nm. The separation was done on C18 column
using 0.1 M KH2PO4 (pH = 7):methanol (55:45 v/v) as a mo-
bile phase. The peak area of NAP, CLO and NAP Deg were
recorded and the peak area (·104) (using 20 lg mL1 of each
Table 4 Summary of the results obtained by applying the diagnostic tools for model validation of the chemometric methods.
Validation parameters NAP CLO NAP Deg
PLS PCR PLS PCR PLS PCR
a – predicted vs. known concentration plot
1 – slope 1.0141 1.0139 0.9921 0.9921 0.9707 0.9706
2 – intercept 0.1469 0.1402 0.0700 0.0700 0.2058 0.2054
3 – correlation coeﬃcient 0.9991 0.9991 0.9997 0.9998 0.9991 0.9990
Residual prediction error 0.68 0.68 0.14 0.14 0.20 0.20
b – RMSEP 0.29 0.29 0.13 0.13 0.16 0.16
Figure 5 TLC chromatogram of a mixture of, (a) naphazoline hydrochloride, (b) chlorpheniramine maleate and (c) naphazoline
hydrochloride degradation product (using: ethyl acetate:methanol:ammonia (8:2:0.5, by volume) as a developing system.
Table 5 Parameters of system suitability of the developed
HPTLC-densitometric method.
Parameters NAP Deg NAP CLO
Symmetry factor 1.02 1.01 1.00
Resolution (Rs) – 2.4 3.1
Capacity factor (K0) 0.78 0.55 0.25
Selectivity (a) – 2.04 1.67
62 Ned Sayed et al.of NAP, CLO and NAP Deg as an external standard) was cal-
culated for each concentration. The calibration curves relating
the obtained peak area ratio to corresponding concentration
were constructed and the regression equations were then
computed.
2.4.5. Application to pharmaceutical formulation
The contents of 10 bottles of each of Nostamine, Neozoline
and Prisoline drops were separately mixed well, then 20 mL
were transferred accurately into a 100-mL volumetric ﬂask;
the volume was completed with methanol to get a 100 lg mL1
working solution of each of NAP and CLO (in spectrophoto-
metric, chemometric and HPTLC-densitometric methods) and
with 0.1 M KH2PO4: methanol (55:45 v/v) (to obtain
100 lg mL1 working solution for each in the HPLC method).3. Results and discussion
NAP and CLO are co-formulated in many pharmaceutical for-
mulations, so, it was necessary to determine each of them in
the presence of the other. CLO is stable against hydrolysis
and no hydrolytic degradation products have been obtained
after forced hydrolysis conditions.29 NAP is liable to hydroly-
sis after reﬂuxing with 1 N NaOH giving 1-naphthalene acetic
acid as a major degradation product after 2 h26 which is also
one of the potential impurities of NAP in both USP27 and
BP28 so the determination of the binary mixture in bulk pow-
der or in their pharmaceutical formulations without interfer-
ence of NAP Deg was an analytical task of potential.
3.1. Derivative and derivative ratio spectrophotometric methods
3.1.1. Fourth derivative (D4) spectrophotometric method
Derivative spectrophotometry offers greater selectivity than
does the normal spectrophotometry, as it decreases spectral
overlap and allows better resolution.32
Fig. 2 shows the severe overlap of the absorption spectra of
NAP, CLO, and NAP Deg which prevents their direct simul-
taneous determination. Different factors affecting separation
were studied to optimize resolution of drugs, including solvent
effect. Different solvents were tried in order to eliminate inter-
ference, e.g., methanol, 0.1 N HCl and 0.1 N NaOH. The best
resolution was obtained by applying D4 for the determination
Table 6 System suitability testing parameters of the HPLC method.
Parameters Obtained
value (NAP)
Obtained
value (CLO)
Obtained
value (NAP Deg)
Reference value27
Resolution – 2.00 2.75 R> 0.8
Relative retention (a) – 1.31 1.29 >1
Tailing factor(T) 1.02 1.4 1.25 <1.5–2 or <2
Capacity factor(K0) 6.07 4.87 3.38 1–10 acceptable
Number of theoretical plates (N) 1744.49 1684.28 1431.00 Increase with eﬃciency
of the separation
HETP 0.014 0.015 0.017 The smaller the value
the higher the column eﬃciency
HETP= height equivalent to theoretical plate, (cm plate1).
Figure 6 HPLC chromatogram of a mixture of naphazoline hydrochloride, chlorpheniramine maleate and naphazoline hydrochloride
degradation product using 0.1 M KH2PO4 (pH= 7):methanol (55:45 v/v) as a mobile phase.
Spectrophotometric, chemometric and chromatographic determination 63of NAP at 302 nm using methanol as solvent. Different param-
eters affecting D4 spectra were investigated; different smooth-
ing factor (Dk) intervals and scaling factor values were tried.
The best condition was obtained by using 8 nm as Dk interval
and the scaling factor, 1000, as shown in Fig. 3.
Linear correlations were obtained between peak amplitudes
of NAP at 302 nm in the concentration range of 5–40 lg mL1
from which the regression equation was calculated and found
to be:
Y ¼ 0:0194Cþ 0:0089; r ¼ 0:9999
where Y is the peak amplitude at 302 nm, C is the concentra-
tion in lg mL1 and r is the correlation coefﬁcient.
Results described in Table 2 show that this method is selec-
tive, valid and applicable for the determination of NAP in the
presence of CLO and up to 40% NAP Deg.
3.1.2. Second derivative of ratio (DD2) spectrophotometric
method
Another method for resolving binary mixtures without previ-
ous separation is the derivative ratio spectrophotometry,
which was developed by Salinas et al.33In this method, the absorption spectra of NAP, CLO and
NAP Deg were divided by the spectrum of 30 lg mL1 of
NAP Deg (as a divisor), and DD2 spectra were obtained,
where CLO could be determined at 276.4 nm as shown in
Fig. 4. Selection of the divisor and its concentration is of great
importance, so different concentrations of NAP (10, 15 20 and
30 lg mL1) and NAP Deg (10, 15, 20 and 30 lg mL1) were
tried as divisors. The best results in terms of signal-to-noise ra-
tio, sensitivity and selectivity were followed using 30 lg mL1
of NAP Deg as a divisor for the determination of CLO.
Linear correlations were obtained between peak amplitudes
of CLO at 276.4 nm in the concentration range of 5–
45 lg mL1 from which the linear regression equation was
computed and found to be:
Y ¼ 0:1296Cþ 0:0131; r ¼ 0:9998
where Y is the peak amplitude at 276.4 nm, C is the concentra-
tion in lg mL1 and r is the correlation coefﬁcient.
Results obtained by applying the suggested DD2 method in
Table 3 show that neither NAP nor NAP Deg inﬂuence the
determination of CLO concentration in the prepared mixtures
containing different ratios of the three components.
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64 Ned Sayed et al.3.2. Chemometric methods
In this method, PLS and PCR chemometric approaches were
applied for the determination of NAP, CLO and NAP Deg
in their ternary mixture. These chemometric methods were use-
ful in spectral analysis because the simultaneous inclusion of
many spectral wavelengths instead of a single wavelength
greatly improved the precision and predictive ability.34 The
ﬁrst step in the simultaneous determination of the three com-
ponents by chemometric methods involved constructing the
calibration matrix for ternary mixture. Seventeen mixtures of
NAP, CLO and NAP Deg with different ratios of each compo-
nent were used for building the calibration model, while eight
mixtures were randomly chosen to be used as an external val-
idation set; their concentrations are given in Table 1. Best re-
sults were obtained using methanol as a solvent, and
rejecting the spectral regions above 300 nm and below
250 nm. In this study, the ‘leave one out’ cross-validation
method was used and the RMSECV values of different devel-
oped models were compared. Four factors were found suitable
to describe the models.
Results of applying the proposed chemometric methods for
the determination of CLO, NAP and NAP deg in the valida-
tion set are given in Table 3.
For evaluation of the predictive abilities of the developed
model, several diagnostic tools were calculated: predictive ver-
sus actual concentration plot (model and sample diagnostic);
and root mean square error of prediction (RMSEP) (model
diagnostic) as shown in Table 4.
3.3. HPTLC-densitometric method
This technique offers a simple way to quantify directly on the
TLC plate by measuring the optical density of the separated
bands. The amounts of compounds are determined by compar-
ing the peak area of the unknown band to a standard curve
from reference materials chromatographed simultaneously un-
der the same condition.35 It is worth mentioning that upon try-
ing the TLC-densitometric method5 found in the literature,
poor resolution of NAP Deg was observed.
The proposed method is based on the difference in the
migration rate of the three components, the Rf values were
found to be 0.22 for NAP Deg, 0.45 for NAP and 0.75 for
CLO (Fig. 5).
The calibration curves were constructed by plotting the
peak area (·104) versus the concentration in the ranges of
0.5–4.5, 0.5–4, and 0.6–1.8 lg band1 for NAP, CLO and
NAP Deg, respectively, the concentration was calculated from
the following regression equation:
Y ¼ 0:1892Cþ 0:0870r ¼ 0:9998 for NAP
Y ¼ 0:1923Cþ 0:0599r ¼ 0:9999 for CLO
Y ¼ 0:2229Cþ 0:0600r ¼ 0:9997 for NAP Deg
where Y is the peak area (·104), C is the concentration in
lg band1 and r is the correlation coefﬁcient.
To improve the separation of bands, it was necessary to
investigate the effect of different variables. Studying the opti-
mum parameters for maximum separation was carried out as
follows:
Table 8 Application of standard addition technique for the determination of naphazoline HCl and chlorpheniramine maleate in Nostamine, Neozoline and Prisoline eye/nose
drops by the proposed methods.
Pharmaceutical
formulations
Spectrophotometric
methods
Chemometric
methods
TLC-densitometric
method
HPLC
method
PLS PCR
Added
lg mL1
Recovery
*%
Mean
± S.D.
Added
lg mL1
Recovery
*%
Mean ±
S.D.
Added
lg mL1
Recovery
*%
Mean ±
S.D.
Added
lg band1
Recovery
*%
Mean ±
S.D.
Added
lg mL1
Recovery
*%
Mean
± S.D.
Nostamine eye/nose drops (Batch No.1101185) labeled to contain 0.5 mg/mL NAP and 0.5 mg/mL CLO
NAP 5 98.39 101.19 ± 2.449 5 102.86 100.66 ± 2.413 5 102.16 100.43 ± 2.168 0.5 100.00 100.44 ± 1.389 5 101.00 100.02 ± 1.692
6 102.22 6 101.05 6 101.14 1 102.00 10 101.00
7 102.95 7 98.08 7 98.00 1.5 99.33 15 98.07
CLO 5 103.21 102.21 ± 1.302 5 98.14 99.79 ± 2.441 5 98.09 100.12 ± 2.289 0.5 102.00 100.84 ± 2.449 5 103.11 102.12 ± 1.564
6 100.74 6 102.60 6 102.60 0.8 102.50 10 100.32
7 102.69 7 98.65 7 99.66 1 98.03 15 102.94
Neozoline eye/nose drops (Batch No. 102301) labeled to contain 0.5 mg/mL NAP and 0.5 mg/mL CLO
NAP 5 101.55 99.27 ± 1.991 5 101.02 100.05 ± 1.779 5 100.87 101.09 ± 0.381 0.5 102.16 99.95 ± 1.923 5 99.60 100.54 ± 1.227
6 97.86 6 101.14 6 100.87 1 99.02 10 100.10
7 98.41 7 98.00 7 101.53 1.5 98.67 15 101.93
CLO 5 98.68 100.53 ± 1.671 5 101.41 100.92 ± 1.892 5 101.41 100.79 ± 2.114 0.5 98.00 98.26 ± 0.427 5 102.40 101.39 ± 0.956
6 101.93 6 102.53 6 102.53 0.8 98.75 10 100.50
7 100.98 7 98.84 4 98.44 1 98.02 15 101.27
Prisoline eye/nose drops (Batch No. 16237) labeled to contain 0.5 mg/mL NAP and 0.5 mg/mL CLO
NAP 5 103.36 101.07 ± 2.566 – – – – – – 0.5 98.00 98.89 ± 1.541 5 102.00 102.68 ± 0.665
6 101.57 1 98.00 10 102.70
7 98.30 1.5 100.67 15 103.33
CLO 5 101.07 100.19 ± 1.803 – – – – – – 0.5 98.00 100.50 ± 2.291 5 100.80 100.51 ± 1.783
6 98.12 0.8 102.50 10 98.60
7 101.39 1 101.00 15 102.13
* Average of 3 determinations.
S
p
ectro
p
h
o
to
m
etric,
ch
em
o
m
etric
a
n
d
ch
ro
m
a
to
g
ra
p
h
ic
d
eterm
in
a
tio
n
6
5
T
a
b
le
9
A
ss
a
y
p
a
ra
m
et
er
s
a
n
d
m
et
h
o
d
v
a
li
d
a
ti
o
n
o
b
ta
in
ed
b
y
a
p
p
ly
in
g
th
e
p
ro
p
o
se
d
m
et
h
o
d
s
fo
r
d
et
er
m
in
a
ti
o
n
o
f
n
a
p
h
a
zo
li
n
e
H
C
l,
ch
lo
rp
h
en
ir
a
m
in
e
m
a
le
a
te
a
n
d
n
a
p
h
a
zo
li
n
e
H
C
l
d
eg
ra
d
a
ti
o
n
p
ro
d
u
ct
.
P
a
ra
m
et
er
s
S
p
ec
tr
o
p
h
o
to
m
et
ri
c
m
et
h
o
d
s
H
P
T
L
C
-d
en
si
to
m
et
ri
c
m
et
h
o
d
H
P
L
C
m
et
h
o
d
N
A
P
C
L
O
N
A
P
C
L
O
N
A
P
D
eg
N
A
P
C
L
O
N
A
P
D
eg
R
a
n
g
e
5
–
4
0
lg
m
L

1
5
–
4
5
lg
m
L

1
0
.5
–
4
.5
l
g
b
a
n
d

1
0
.5
–
4
lg
b
a
n
d

1
0
.6
–
1
.8
lg
b
a
n
d

1
5
–
3
7
lg
m
L

1
5
–
5
0
l
g
m
L

1
5
–
3
5
lg
m
L

1
L
in
ea
ri
ty
S
lo
p
e
0
.0
1
9
4
0
.1
2
9
6
0
.1
8
9
2
0
.1
9
2
3
0
.2
2
2
9
0
.1
7
7
6
0
.1
3
4
7
0
.2
3
8
6
In
te
rc
ep
t
0
.0
0
8
9
0
.0
1
3
1
0
.0
8
7
0
0
.0
5
9
9
0
.0
6
0
0
0
.0
3
6
2
0
.0
0
2
1
0
.0
4
3
0
C
o
rr
el
a
ti
o
n
co
eﬃ
ci
en
t
0
.9
9
9
9
0
.9
9
9
8
0
.9
9
9
8
0
.9
9
9
9
0
.9
9
9
7
0
.9
9
9
8
0
.9
9
9
9
0
.9
9
9
9
A
cc
u
ra
cy
M
ea
n
±
S
.D
.
9
9
.7
2
±
1
.6
4
0
9
9
.8
8
±
1
.4
8
1
1
0
0
.4
0
±
1
.1
4
3
1
0
0
.2
6
±
0
.7
8
5
1
0
0
.4
5
±
0
.6
5
9
1
0
0
.2
9
±
1
.2
5
8
1
0
0
.4
8
±
1
.6
6
0
9
9
.9
7
±
1
.1
1
3
S
p
ec
iﬁ
ci
ty
1
0
0
.1
4
±
2
.5
2
2
9
8
.1
3
±
0
.9
8
1
–
–
–
–
–
–
P
re
ci
si
o
n
(
R
.S
.D
.
%
)
R
ep
ea
ta
b
il
it
y
*
1
.3
2
4
0
.8
9
7
0
.3
5
5
0
.1
7
4
0
.7
5
3
0
.2
9
3
0
.8
9
9
0
.4
1
5
In
te
rm
ed
ia
te
P
re
ci
si
o
n
*
1
.7
6
2
1
.5
5
4
0
.4
7
1
0
.3
5
3
0
.6
5
8
0
.4
8
6
0
.9
5
9
0
.8
1
8
L
O
D
*
*
1
.4
6
2
.1
8
0
.1
5
0
.1
4
0
.1
3
0
.1
4
2
.1
1
1
.8
1
L
O
Q
*
*
4
.5
8
4
.8
4
0
.4
5
0
.4
3
0
.4
9
0
.4
2
4
.6
1
4
.0
9
*
T
h
e
in
tr
a
-d
a
y
p
re
ci
si
o
n
(n
=
3
),
a
v
er
a
g
e
o
f
th
re
e
d
if
fe
re
n
t
co
n
ce
n
tr
a
ti
o
n
s
re
p
ea
te
d
th
re
e
ti
m
es
w
it
h
in
d
a
y
.
T
h
e
in
te
r-
d
a
y
p
re
ci
si
o
n
(n
=
3
),
a
v
er
a
g
e
o
f
th
re
e
d
if
fe
re
n
t
co
n
ce
n
tr
a
ti
o
n
s
re
p
ea
te
d
th
re
e
ti
m
es
in
th
re
e
su
cc
es
si
v
e
d
a
y
s.
*
*
L
O
D
=
(S
D
o
f
th
e
re
sp
o
n
se
/s
lo
p
e)
·
3
.3
;
L
O
Q
=
(S
D
o
f
th
e
re
sp
o
n
se
/s
lo
p
e)
·
1
0
.
66 Ned Sayed et al.Different developing systems with different ratios were
tried, but a complete separation of NAP, CLO and NAP
Deg was achieved by using ethyl acetate:methanol:ammonia
solution (8:2:0.5, by volume).
Also different scanning wavelengths were tested like 220
and 265 nm, but on using 245 nm the separated peaks were
more sharp and symmetrical with minimum noise.
Parameters including resolution (Rs), peak symmetry,
capacity factor (K0) and selectivity factor (a) were calculated.
The resolution is always above two, the selectivity more than
one and accepted values for symmetry factor were obtained,
as shown in Table 5.
3.4. HPLC method
A validated isocratic RP-HPLC method with UV detection
was developed for the quantitation of NAP, CLO and NAP
Deg. It depends on the chromatographic separation of the
three components using ODS C18 column (25 cm · 4.6 mm
i.d. 5 lm particle size) and the mobile phase used consisted
of 0.1 M KH2PO4 (pH = 7):methanol (55:45 v/v). The mobile
phase was delivered at a constant ﬂow rate of 1.5 mL min1.
The injection volume was 20 lL and the efﬂuent was UV-de-
tected at 265 nm.
The relationship between the peak areas (·104) and the
concentrations of NAP, CLO and NAP Deg were investigated.
The linear relationships were tested, resulting in good correla-
tion coefﬁcients in the ranges of 5–37, 5–50 and 5–35 lg mL1
for NAP, CLO and NAP Deg, respectively. The regression
equations were computed and found to be:
Y ¼ 0:1776Cþ 0:0362r ¼ 0:9998 for NAP
Y ¼ 0:1347Cþ 0:0021r ¼ 0:9999 for CLO
Y ¼ 0:2386Cþ 0:0430r ¼ 0:9999 for NAP Deg
where, Y is relative peak area, C is the concentration in
lg mL1, and r is the correlation coefﬁcient. The regression
equation parameters demonstrated in Table 6 revealed that
the suggested method is accurate, precise and speciﬁc over
the speciﬁed ranges.
3.4.1. Optimization of the RP-HPLC method
To optimize the proposed RP-HPLC method, it was necessary
to test the effect of different parameters that affect the sensitiv-
ity, selectivity and the efﬁciency of the chromatographic
separation.
3.4.1.1. pH effect. The effect of pH on separation was tested by
using phosphate buffer at different pH values, it was found
that the best pH value was pH = 7. Also the strength of buffer
has a great effect on the separation of the three components,
0.1 M KH2PO4 was better than 0.025 and 0.05 M.
3.4.1.2. Mobile phase. Different systems were tried to achieve
the best chromatographic separation. Complete separation of
the three peaks has been obtained upon using 0.1 M KH2PO4
(pH= 7):methanol (55:45 v/v) as a mobile phase.
3.4.1.3. Instrumental parameters. Different stationary phases
(C8 and C18) have been tested to optimize the resolution of
the three studied components. ODS C18 column gave the best
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Spectrophotometric, chemometric and chromatographic determination 67separation with the optimum resolution of the three studied
components. Different scanning wavelengths have been tested
in a trial to enhance the sensitivity of the method. The opti-
mum wavelength for the detection of the three components
was at 265 nm. Also different ﬂow rates have been tried to ob-
tain maximum separation within reasonable analysis time, and
delivering the mobile phase at 1.5 mL min1 was found suit-
able for complete separation and good resolution.
The respective compounds were well separated at reason-
able retention time. Where, NAP was eluted at 3.93 min,
CLO after 5.13 min and NAP Deg after 6.62 min as shown
in Fig. 6.
The suggested methods are valid and applicable for the
analysis of NAP and CLO in their pharmaceutical formula-
tions (Nostamine, Neozoline and Prisoline drops)
(except for the chemometric method which was unable to
determine the proposed drugs in Prisoline drops due to inter-
ference from additives) as shown in Table 7. Furthermore, the
validity of the proposed methods was assessed by applying the
standard addition technique, which showed accurate results
and there was no interference from eye drop excipients as
shown in Table 8.
Method validation was performed according to USP guide-
lines27 for all the proposed methods. Table 9 shows results of
accuracy, repeatability and intermediate precision of the deriv-
ative and derivative ratio spectrophotometric, HPTLC-densi-
tometric and HPLC methods.
Table 10 shows a statistical comparison of the results ob-
tained by the proposed methods and the reported method.5
The calculated t and F values are less than the theoretical ones
indicating that there is no signiﬁcant difference between the
proposed methods and the reported method with respect to
accuracy and precision.
4. Conclusion
No reported method has been reported for a simultaneous
determination of NAP and CLO in the presence of NAP
Deg whose UV spectra display complete overlap with NAP
and CLO. So the aim of this work was to develop recent, sim-
ple, sensitive and validated stability indicating methods for the
determination of the two proposed drugs in their binary mix-
ture and in the presence of NAP Deg.
There is only one reported spectrophotometric method con-
cerned with the determination of NAP and CLO in their binary
mixture, upon trying this method, it failed to determine either
NAP or CLO in the presence of NAP Deg, on the other hand,
the proposed spectrophotometric method determined both
NAP and CLO successfully in the presence of NAP Deg, so it
is considered as a stability indicating method.
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